双特异性平台banner
SCIENCE AND TECHNOLOGY
 
科学与技术
about banner
SCIENCE AND TECHNOLOGY
科学与技术
加入我们
SCIENCE AND TECHNOLOGY
科学与技术

科学发表

LBL-007 (anti-LAG3 monoclonal antibody):

“Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy”. 发表于 MABS 2019 (论文)。

LBL-024:a bispecific antibody:

“An anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model” 被2021-AACR接受为墙报

LBL-015:a bispecific fusion protein:

“A novel anti-PD-1 fused with TGF-βR2, shows a great anti-tumor activity in a mouse MC38 model” 被2021-AACR接受为墙报

LBL-007 (anti-LAG3 monoclonal antibody):

“Phase I study of LBL-007, a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody in patients with advanced solid tumors” 被2021-ASCO接受为墙报

微信二维码

  总部和研发中心:南京市建邺区嘉陵江东街18号3幢7层
     中试和生产:南京市江北新区华康路122号05栋
 025-83378099      wlzb@leadsbiolabs.com

Leads Biolabs © 南京维立志博生物科技有限公司  |  苏ICP备18069235号-1